4[1]Ganz PA, Figlin RA, Haskell CM, et al. Supportive care versus supportive care and chemotherapy in metastatic nonsmall cell lung cancer: Doses chemotherapy make a difference?[J]. Cancer, 1998 ;6(1): 1271 - 1278.
5[3]Pasquini E, Tassinari D, Niconlini M, et al. Gemcitabine in advanced NSCLC of elderly:A phase Ⅱ study[J]. Ann Oncol,1998 ;4(suppl): A154 - 157.
6[4]Klastersky J, Sculier JP. Dose - finding study of paclitaxel plus cisplatin in patients with non- small cell lung cancer[J].Lung Cancer, 1995; 12(suppl): 117 - 125.
7SEHESTED M,HIRSCH F R,OSTERLIND K,et al.Morphologic variations of small cell lung cancer.A histopathologic study of pretreatment and posttreatment specimens in104patients[J].Cancer,1986,57(4):804-807.
8TAN E H,ANG P T,WEE J,et al.Vinorelbine,ifosfamide and cisplatin in advanced non-small cell lung cancer[J].Acta Oncol,1999,38(5):619-622.
9TOGNONI A,CADENOTTI L,PENSA F,et al.A phaseⅡstudy of a three-drug combination(cisplatin,ifosfamide and vinorelbine)plus granulocytecolony stimulating factor in advanced non small cell lung cancer[J].J Chemother,1999,11(4):306-309.
10TRAVIS W D,BRAMBILL A E,MULLER-HERMELINK H K,et al.Pathology and genetics of tumours of the lung,pleura,thymus and heart[M].Lyon:IARC Press,2004:31-34.
